Economic Inequities in the Application of Neuromodulation Devices
- PMID: 31720154
- PMCID: PMC6823036
- DOI: 10.7759/cureus.5685
Economic Inequities in the Application of Neuromodulation Devices
Abstract
Background There is a significant upfront cost for the use of neuromodulation devices. The high cost of these devices may lead to disproportionate application in geographical regions with different levels of financial resources. The purpose of this study was to determine if there is geographic based economic inequity in the application of neuromodulation devices in the United States. Methods Population and average household income data by county from the year 2010 were obtained from publicly available databases on the US Census website. The number of stimulators sold by county in the years 2009 and 2010 were provided by two of the four neuromodulation companies with commercially available products. Pearson correlation and t-test statistics were performed. Results Of the 3142 U.S. counties analyzed, only 689 placed neuromodulation devices during this period of time. There was a difference in average household income between counties with device implants ($49,663) and counties with no device implants ($41,314), which was statistically significant (p<0.001). Conclusion Analysis of neuromodulation devices placed in 2009 and 2010 from 50% of neuromodulation companies demonstrated that there was an income disparity between counties in which implantation of devices occurred and counties in which there were no device implantations.
Keywords: economic inequity; household income; medical economics; neuromodulation; spinal cord stimulation; vagal nerve stimulation.
Copyright © 2019, Leiphart et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures



References
-
- A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures. The Vagus Nerve Stimulation Study Group. Neurology. 1995;45:224–230. - PubMed
-
- Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Rush AJ, Marangell LB, Sackeim HA, et al. Biol Psychiatry. 2005;58:347–354. - PubMed
-
- Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Rush AJ, Sackeim HA, Marangell LB, et al. Biol Psychiatry. 2005;58:355–363. - PubMed
-
- Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. The Deep Brain Stimulation for Parkinson's Disease Study Group. N Engl J Med. 2001;345:956–963. - PubMed
-
- A randomized trial of deep-brain stimulation for Parkinson's disease. Deuschl G, Schade-Brittinger C, Krack P, et al. N Engl J Med. 2006;355:896–908. - PubMed
LinkOut - more resources
Full Text Sources